A single Phase 3 trial failure costs between $800 million and $1.4 billion — including lost time-to-market. The leading cause is patient recruitment. Hekma eliminates that risk before your trial starts.
30–50% of all clinical trial delays are caused by patient recruitment failures. The cost of a one-month delay in a Phase 3 program is $600K–$8M in direct costs alone. (McKinsey, 2024 / Tufts CSDD)
Candidates identified
0Pre-screened
0Referred to sites
0Enrolled
03.3% conversion · industry-best
$40K–$80K
average cost per enrolled patient — traditional recruitment
Medidata, 2024
20%
over-recruitment buffer pharma builds in just to compensate for dropout
Tufts CSDD
$1.4B
average Phase 3 failure cost — majority from enrollment failure
Roots Analysis, 2025
THE PLATFORM
We find your patients. EHR matching across our hospital network, AI matching via H360, targeted digital campaigns — we identify, screen, and deliver pre-qualified candidates for your specific trial, indication, and geography.
Once enrolled, we manage your trial. Protocol management, adverse event tracking, blinded study management, 21 CFR Part 11 compliance, and multi-site coordination — deployed in weeks, not months.
Veeva Basics and Medidata were built for companies running 50+ trials. Hekma is built for startups running their first three. Per-trial model. Deploy in days. One platform, not four vendor contracts.
DISEASE VERTICALS WE COVER
Heart failure, AFib, hypertension, cardiometabolic conditions
Solid tumors, hematologic malignancies, immuno-oncology, precision oncology
Alzheimer's, Parkinson's, multiple sclerosis, rare neurological disorders
Ultra-specific patient populations. PAG partnerships. H360 rare disease registry.
Class II/III device trials, SaMD validation, post-market surveillance (522 studies, PMCF)
SMB Pharma & Biotech
Enterprise recruitment without enterprise price or timeline
Medical Devices
Device-specific EHR matching — CPT codes, UDI, surgical notes
Patient Recruitment
5 recruitment failures solved — from screen failure to rare disease
AI Trial Matching
Know exactly how many eligible patients exist before you commit
EHR Aggregation & AI
Aggregate records across 5 providers. Read by AI in hours.
CTMS for Pharma
Live in days. Not months. Built for first-three-trials teams.
Give us your protocol. We'll show you how many eligible patients exist in our network, where they are, and how fast you can enroll — before you commit to a timeline.